Prevalence and correlates of insomnia and its impact on quality of life in Chinese schizophrenia patients

Sleep

Volumn 32, Issue 1, 2009, Pages 105-109

  Xiang, Yu Tao ^a,b,c   Weng, Yong Zhen ^b   Leung, Chi Ming ^a   Tang, Wai Kwong ^a   Lai, Kelly Y C ^a   Ungvari, Gabor S ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c SHATIN HOSPITAL   (Hong Kong)

Author keywords

China; Hong kong; Insomnia; Quality of life; Schizophrenia

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE; HYPNOTIC AGENT;

ADULT; ARTICLE; CHINA; CHINESE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; FEMALE; HONG KONG; HOSPITAL ADMISSION; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MENTAL HOSPITAL; OUTPATIENT; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOM SAMPLE; SCHIZOPHRENIA; SOCIOECONOMICS; STATISTICAL SIGNIFICANCE; COMORBIDITY; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; CULTURAL FACTOR; ETHNOLOGY; MIDDLE AGED; PSYCHOLOGICAL ASPECT; PSYCHOLOGY;

ADULT; CHINA; COMORBIDITY; CROSS-CULTURAL COMPARISON; CROSS-SECTIONAL STUDIES; FEMALE; HONG KONG; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SLEEP INITIATION AND MAINTENANCE DISORDERS;

EID: 61549092784     PISSN: 01618105     EISSN: 15509109     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Hetta J, Broman JE, Mallon L. Evaluation of severe insomnia in the general population - implications for the management of insomnia: insomnia, quality of life and healthcare consumption in Sweden. J Psychopharmacol 1999;13:S35-6.
2. Leger D, Poursain B. An international survey of insomnia: under-recognition and under-treatment of a polysymptomatic condition. Curr Med Res Opin 2005;21:1785-92.
3. Katz DA, McHorney CA. Clinical correlates of insomnia in patients with chronic illness. Arch Intern Med 1998;158:1099-107.
4. McCall WV, Reboussin BA, Cohen W. Subjective measurement of insomnia and quality of life in depressed inpatients. J Sleep Res 2000;9:43-8.
5. Ohayon MM. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev 2002;6:97-111.
6. Kaplan RM. Quality of life: an outcomes perspective. Arch Phys Med Rehabil 2002;83:S44-50.
7. Corrigan PW, Buican B. The construct validity of subjective quality of life for the severely mentally ill. J Nerv Ment Dis 1995;183:281-5.
8. Browne S, Roe M, Lane A, et al. Quality of life in schizophrenia: relationship to sociodemographic factors, symptomatology and tardive dyskinesia. Acta Psychiatr Scand 1996;94:118-24.
9. Meltzer HY, Burnett S, Bastani B, Ramirez LF. Effects of six months of clozapine treatment on the quality of life of chronic schizophrenic patients. Hosp Community Psychiatry 1990;41:892-7.
10. Bechdolf A, Klosterkotter J, Hambrecht M, et al. Determinants of subjective quality of life in post acute patients with schizophrenia. Eur Arch Psychiatry Clin Neurosci 2003;253:228-35.
11. Ritsner M, Ponizovsky A, Endicott J, et al. The impact of side-effects of antipsychotic agents on life satisfaction of schizophrenia patients: a naturalistic study. Eur Neuropsychopharmacol 2002;12:31-8.
12. Russo J, Roy-Byrne P, Reeder D, et al. Longitudinal assessment of quality of life in acute psychiatric inpatients: reliability and validity. J Nerv Ment Dis 1997;185:166-75.
13. Ritsner M, Kurs R, Ponizovsky A, Hadjez J. Perceived quality of life in schizophrenia: relationships to sleep quality. Qual Life Res 2004;13:783-91.
14. Warner R, de Girolamo G, Belelli G, Bologna C, Fioritti A, Rosini G. The quality of life of people with schizophrenia in Boulder, Colorado, and Bologna, Italy. Schizophr Bull 1998;24:559-68.
15. Gureje O, Makanjuola VA, Kola L. Insomnia and role impairment in the community: results from the Nigerian survey of mental health and wellbeing. Soc Psychiatry Psychiatr Epidemiol 2007;42:495-501.
16. Ohayon MM, Partinen M. Insomnia and global sleep dissatisfaction in Finland. J Sleep Res 2002;11:339-46.
17. Xiang YT, Weng YZ, Leung CM, Tang WK, Ungvari GS. Subjective quality of life in outpatients with schizophrenia in Hong Kong and Beijing: relationship to socio-demographic and clinical factors. Qual Life Res 2008;17:27-36.
18. Lobana A, Mattoo SK, Basu D, Gupta N. Quality of life in schizophrenia in India: comparison of three approaches. Acta Psychiatr Scand 2001;104:51-5.
19. Laux G, Konig W. Long-term use of benzodiazepines in psychiatric inpatients. Acta Psychiatr Scand 1987;76:64-70.
20. Sim K, Su A, Leong JY, et al. High dose antipsychotic use in schizophrenia: findings of the REAP (research on east Asia psychotropic prescriptions) study. Pharmacopsychiatry 2004;37:175-9.
21. Overall JE, Beller SA. The Brief Psychiatric Rating Scale (BPRS) in geropsychiatric research: I. Factor structure on an inpatient unit. J Gerontol 1984;39:187-93.
22. Shin SK, Lukens EP. Effects of psychoeducation for Korean Americans with chronic mental illness. Psychiatr Serv 2002;53:1125-31.
23. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
24. Simpson GM, Angus JW. A rating scale for extrapyramidal side effects. Acta Psychiatr Scand 1970;45(Suppl. 212):11-9.
25. Barnes TR. A rating scale for drug-induced akathisia. Br J Psychiatry 1989;154:672-6.
26. Rudnick A. The impact of coping on the relation between symptoms and quality of life in schizophrenia. Psychiatry 2001;64:304-8.
27. WHO. Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group. Psychol Med 1998;28:551-8.
28. Fang JQ, Hao YT, Li CX. Reliability and validity for Chinese version of WHO quality of life scale (in Chinese). Chinese Mental Health Journal 1999;13:203-5.
29. Rocha FL, Guerra HL, Lima-Costa MF. Prevalence of insomnia and associated socio-demographic factors in a Brazilian community: the Bambui study. Sleep Med 2002;3:121-6.
30. Zammit GK, Weiner J, Damato N, Sillup GP, McMillan CA. Quality of life in people with insomnia. Sleep 1999;22 (Suppl 2M:S379-85.
31. Dursun SM, Patel JK, Burke JG, Reveley MA. Effects of typical antipsychotic drugs and risperidone on the quality of sleep in patients with schizophrenia: a pilot study. J Psychiatry Neurosci 1999;24:333-7.
32. Shen YC. Psychiatry. Beijing: People's Medical Publishing House, 2002.
33. Taylor D, Paton C, Kerwin R. The Maudsley Prescribing Guidelines (2005-2006). Abingdon: Taylor & Francis, 2005.
34. Wolf B, Grohmann R, Biber D, Brenner PM, Ruther E. Benzodiazepine abuse and dependence in psychiatric inpatients. Pharmacopsychiatry 1989;22:54-60.
35. Ohayon M. Epidemiological study on insomnia in the general population. Sleep 1996;19:7-15.
36. Ritsner M, Modai I, Endicott J, et al. Differences in quality of life domains and psychopathologic and psychosocial factors in psychiatric patients. J Clin Psychiatry 2000;61:880-9.
37. Awad AG, Voruganti LN, Heslegrave RJ. A conceptual model of quality of life in schizophrenia: description and preliminary clinical validation. Qual Life Res 1997;6:21-6.
38. Becker M, Diamond R, Sainfort F. A new patient focused index for measuring quality of life in persons with severe and persistent mental illness. Qual Life Res 1993;2:239-51.
39. Bigelow DA, McFarland BH, Olson MM. Quality of life of community mental health program clients: validating a measure. Community Ment Health J 1991;27:43-55.
40. Lehman AF, Ward NC, Linn LS. Chronic mental patients: the quality of life issue. Am J Psychiatry 1982;139:1271-6.
41. Nuechterlein KH, Dawson ME. A heuristic vulnerability/stress model of schizophrenic episodes. Schizophr Bull 1984;10:300-12.
42. Taylor D, Paton C, Kerwin R. The Maudsley Prescribing Guidelines. London: Martin Dunitz, 2003.
43. Ungvari GS, Chung YG, Chee YK, Fung-Shing N, Kwong TW, Chiu HF. The pharmacological treatment of schizophrenia in Chinese patients: a comparison of prescription patterns between 1996 and 1999. Br J Clin Pharmacol 2002;54:437-44.